STAT22m
Pharmalittle: We’re reading about FTC criticizing PBMs, a NIH policy on access to medicines, and more
The FDC released a second highly critical report of PBMs, which may provide further impetus for legislative action to curb ...
Hosted on MSN27m
'Raking in billions': Report shows Drug middlemen jack up prices by nearly 8,000%
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
Hosted on MSN26m
3 Dividend Stocks at Bargain Levels to Defend Your Portfolio
As 2025 kicks off with a volatile start, many investors are likely feeling the pressure of heightened uncertainty. The S&P ...
BioSpace42m
Pharmacy Benefits Managers Netted Extra $7.3 Billion by Inflating Drug Prices: FTC
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
kffhealthnews57m
FTC Finds Top Three PBMs Took In Billions From Inflated Drug Costs
During a roughly five-year span, CVS Health, Cigna, and UnitedHealth benefited the most from increasing prices for generic drugs that treated illnesses such as HIV and cancer. Some of the price hikes ...